Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
Title:
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
Author:
Platzbecker, Uwe Germing, Ulrich Götze, Katharina S Kiewe, Philipp Mayer, Karin Chromik, Jörg Radsak, Markus Wolff, Thomas Zhang, Xiaosha Laadem, Abderrahmane Sherman, Matthew L Attie, Kenneth M Giagounidis, Aristoteles